Wednesday, December 26, 2018 2:08:34 PM
Now, to the question of why we're dropping. First, let's recognize that the market is not rational in the short term, so applying rational analysis has to be done with that in mind. It may be that there's no reason at all!
On the other hand, there are factors that make Pluristem vulnerable. It's a small company, it's in Israel (less awareness by the market), manipulation by financial interests, tough biotech market, EOY selling, etc..
I would dismiss any wild speculation as.... wild speculation. What is concrete is the excellent results as seen by Dr.Landis and others in the clinic (vs unsupported assertions by an anonymous voice from the ether: "Eich" ... which is more credible?)
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM